Lizhu Weng

10# Zhenhai Road
Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study.

Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study.

Journal: Cancer treatment and research communications

Published: July 22, 2025

Evaluating safety risks of ischaemic colitis with taxanes: a disproportionality analysis based on FDA adverse event Reporting system.

Evaluating safety risks of ischaemic colitis with taxanes: a disproportionality analysis based on FDA adverse event Reporting system.

Journal: Expert opinion on drug safety

Published: July 02, 2025

Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study.

Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study.

Journal: BMC pharmacology & toxicology

Published: November 17, 2023

Randomized controlled trial of an app for cancer pain management.

Randomized controlled trial of an app for cancer pain management.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: September 25, 2023

Post-marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.

Post-marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.

Journal: British journal of clinical pharmacology

Published: February 09, 2023

Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.

Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.

Journal: The journal of allergy and clinical immunology. In practice

Published: June 11, 2022

Benefits of Mobile Apps for Cancer Pain Management: Systematic Review.

Benefits of Mobile Apps for Cancer Pain Management: Systematic Review.

Journal: JMIR mHealth and uHealth

Published: November 14, 2019

Development and Testing of a Mobile App for Pain Management Among Cancer Patients Discharged From Hospital Treatment: Randomized Controlled Trial.

Development and Testing of a Mobile App for Pain Management Among Cancer Patients Discharged From Hospital Treatment: Randomized Controlled Trial.

Journal: JMIR mHealth and uHealth

Published: October 18, 2018

Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China.

Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China.

Journal: Clinical therapeutics

Published: September 08, 2018

Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.

Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 20, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026